This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Abnova
product type :
antibody
product name :
GAD2 monoclonal antibody, clone N-GAD65
catalog :
MAB12482
quantity :
50 ug
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
N-GAD65
reactivity :
human
application :
western blot, immunoprecipitation, radioimmunoassay, immunohistochemistry - paraffin section
product information
catalog id :
MAB12482
product name :
GAD2 monoclonal antibody, clone N-GAD65
product description :
Mouse monoclonal antibody raised against partial synthetic peptide of human GAD2.
clone name :
N-GAD65
isotype :
IgG1
gene name :
GAD2
gene alias :
GAD65 MGC161605 MGC161607
gene description :
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)
immunogen :
A synthetic peptide (conjugated with KLH) corresponding to amino acids 4-22 at the N-terminus of human GAD2.
immunogen sequence protein sequence :
PGSGFWSFGSEDGSGDSEN
protein accession :
Q05329
form :
Liquid
recommend dilutions :
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (5 ug/mL). Immunoprecipitation. Radioimmunoassay. Western Blot (1:100-1:1000). The optimal working dilution should be determined by the end user.
storage buffer :
In PBS (0.09% sodium azide)
storage instruction :
Store at 4 C. For long term storage store at -20 C. Aliquot to avoid repeated freezing and thawing.
note :
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
type clonality :
Antibody
raised in host species :
Mouse
antigen species target species :
Human
species reactivity cross reactivity :
Human
application key :
WB,IP,RIA,IHC-P
size :
50 ug
autodate :
2015-12-31
updatetime :
2015-12-31 16:35:02
company information

Abnova
9th Fl., No.108, Jhouzih St.
Neihu District. Taipei City
114 Taiwan
Neihu District. Taipei City
114 Taiwan
sales@abnova.com
https://www.abnova.com877-853-6098
questions and comments